Next-Generation Drug-Eluting Stent Market

Next-generation drug-eluting stent is advantageous as it offers improved deliverability by using materials like cobalt chromium, cobalt nickel, and cobalt alloy, this results in significant reduction in strut width, and enhance stent flexibility. In next-generation drug eluting stent, several drugs are coated in stents to address multiple restenosis pathways by altering drug release kinetics that mimics restenosis cascade. In addition, next-generation drug-eluting stent utilizes bioabsorbable polymers to reduce complications of late stent thrombosis, and bioresorbable drug-eluting scaffold plays a vital role in transforming coronary artery disease treatment.

Next-Generation Drug-Eluting Stent Market contains market size and forecasts of Next-Generation Drug-Eluting Stent in global, including the following market information:

Global Next-Generation Drug-Eluting Stent Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Next-Generation Drug-Eluting Stent Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Next-Generation Drug-Eluting Stent companies in 2021 (%)

The global Next-Generation Drug-Eluting Stent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cobalt Chromium Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Next-Generation Drug-Eluting Stent include Abbott, Biosensors International, Medtronic, Sorin Group, SMT and Terumo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Next-Generation Drug-Eluting Stent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Next-Generation Drug-Eluting Stent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next-Generation Drug-Eluting Stent Market Segment Percentages, by Type, 2021 (%)

Cobalt Chromium

Stainless Steel

Others

Global Next-Generation Drug-Eluting Stent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next-Generation Drug-Eluting Stent Market Segment Percentages, by Application, 2021 (%)

Hospitals

Clinics

Ambulatory Surgical Centers

Global Next-Generation Drug-Eluting Stent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Next-Generation Drug-Eluting Stent Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Next-Generation Drug-Eluting Stent revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Next-Generation Drug-Eluting Stent revenues share in global market, 2021 (%)

Key companies Next-Generation Drug-Eluting Stent sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Next-Generation Drug-Eluting Stent sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott

Biosensors International

Medtronic

Sorin Group

SMT

Terumo